Aditxt Inc
ADTX - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.00 |
|---|---|
| Enterprise Value | $3.96 Million |
| Earnings per Share | $-1153.83 |
| Beta | 0.93 |
| Outstanding Shares | 20,174 |
Return
| Return on Equity | 129554.44% |
|---|---|
| Return on Assets | -310004.11% |
| Return on Invested Capital | -3462162.23% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.24 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.07 |
| Debt to Equity | -0.13 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$-224553600000.00
Consensus analyst estimateRevenue Estimate
$1.00 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 2, 2026
EPS Estimate
$-24408000000.00
Consensus analyst estimateRevenue Estimate
$1.00 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Aditxt Inc
43 employees
Aditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. The immune monitoring technology is designed to provide a personalized comprehensive profile...